Neoadjuvant or Adjuvant Sirolimus for Malignant Metastatic or Locally Advanced Perivascular Epithelioid Cell Tumors

Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000324
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Malignant Perivascular Epithelioid Cell Tumor of the Nasal Cavity

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2016English

Primary Hepatic Perivascular Epithelioid Cell Tumors: Imaging Findings With Histopathological Correlation

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2019English

Malignant Perivascular Epithelioid Cell Tumor Arising in the Mesentery: A Case Report

Oncology Letters
Cancer ResearchOncology
2015English

Phase I and Pharmacokinetic Study of Pemetrexed Plus Cisplatin in Chemonaive Patients With Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Cancer
Cancer ResearchOncology
2009English

Pigmented/Melanocytic Malignant Perivascular Epithelioid Cell Tumor With TFE3-SFPQ(PSF) Rearrangement – A Challenging Diagnosis of PEComa Family of Tumors

Polish Journal of Pathology
MedicineForensic MedicinePathology
2019English

Extrarenal Perivascular Epithelioid Cell Tumors (PEComas) Respond to mTOR Inhibition: Clinical and Molecular Correlates

International Journal of Cancer
Cancer ResearchOncology
2012English

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients With Refractory, Locally Advanced or Metastatic Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2011English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy